Records 1 - 30
| Association between rs735482 polymorphism and risk of cancer: A meta-analysis of 10 case-control studies.
Medicine 2022 Jul 101 (30): e29318.
Xue Shilin, Shen Wenya, Cai Jianning, Jia Jinhai, Zhao Dan, Zhang Shan, Zhao Xiujun, Ma Ning, Wang Wenjuan, Wang Bingshuang, Zhang Xiaolin, Liu Xueh
| Association between ERCC1 Gene Polymorphism (rs11615) and Colorectal Cancer Susceptibility: A Meta-Analysis of Medical Image Fusion and Safety Applications.
Computational and mathematical methods in medicine 2022 2022 9988513.
Liu Min, Qiu Zhifeng, Yang
| Association of ERCC1 rs11615 Polymorphism with the Risk of Cervical Cancer Especially in Chinese Populations: A Meta-Analysis.
Journal of oncology 2022 2022 1790993.
Zhang Yufeng, Teng Yue, Zhu Yuanjie, Wu Yi, Wen Yuting, Liu Xinjian, Li Da
| Prognostic significance of excision repair cross complementation group 1 rs2298881 in patients with gastric cancer receiving platinum-based chemotherapy: A PRISMA-compliant meta-analysis.
Medicine 2021 Aug 100 (33): e26850.
Lv Yalei, Xu Mengyuan, Sun Yidan, Liu Yezhou, Zhao Lijuan, Liu Xuehui, Li Zixuan, Shi Gaiping, Jia Jinhai, Bi Lanfei, Ma Ning, Zhang Xiaolin, Qi Che
| ERCC1 rs11615 polymorphism and chemosensitivity to platinum drugs in patients with ovarian cancer: a systematic review and meta-analysis.
Journal of ovarian research 2021 Jun 14 (1): 80.
Zhang Yuqiang, Cao Sufen, Zhuang Chunyu, Chen Jiacheng, Chen Xiaojing, Sun Hong, Lin Shengying, Lin Baila
| Predictive Value of Excision Repair Cross-Complementation Group 1 in the Response to Platinum-Based Chemotherapy in Esophageal Cancer: A Meta-Analysis.
Oncology research and treatment 2020 Jan 1-9.
Zhuo Ze-Guo, Zhu Yun-Ke, Deng Han-Yu, Li Gang, Luo Jun, Alai Gu-Ha, Lin Yi-D
| Association of ERCC1 and ERCC2 Gene Polymorphisms with Pancreatic Cancer Risk: A Meta-Analysis.
Critical reviews in eukaryotic gene expression 2020 30 (3): 231-237.
Xie Fuyi, Sun Qi, Zhang En, Mu Yin
| Genetic polymorphisms and pancreatic cancer risk: A PRISMA-compliant systematic review and meta-analysis.
Medicine 2019 Aug 98 (32): e16541.
Dai Peng, Li Jing, Li Weibin, Qin Xueliang, Wu Xiaoyong, Di Weidong, Zhang Yanzho
| Association of excision repair cross-complimentary group 1 gene polymorphisms with breast and ovarian cancer susceptibility.
Journal of cellular biochemistry 2019 May .
Yang Fan, Mu Xiyan, Bian Ce, Zhang Huan, Yi Tao, Zhao Xia, Lin Xiaoju
| ERCC1 rs11615 polymorphism increases susceptibility to breast cancer: a meta-analysis of 4547 individuals.
Bioscience reports 2018 May .
Li Bingjie, Shi Xiaoqing, Yuan Yingying, Peng Mengle, Jin Huifang, Qin Dongch
| ERCC1 rs3212986 A/C polymorphism is not associated with chemotherapy treatment outcomes in gastric cancer patients: evidence from 11 publications in Chinese populations.
OncoTargets and therapy 2018 11 1-8.
Tang Weiwei, Wang Hanjin, Wang Yuemei, Wang Xiaow
| Genetic variants as ovarian cancer first-line treatment hallmarks: A systematic review and meta-analysis.
Cancer treatment reviews 2017 Dec 61 35-52.
Assis Joana, Pereira Carina, Nogueira Augusto, Pereira Deolinda, Carreira Rafael, Medeiros R
| Functional genetic variants of XRCC4 and ERCC1 predict survival of gastric cancer patients treated with chemotherapy by regulating the gene expression.
Molecular carcinogenesis 2017 Aug .
Cheng Lei, Qiu Lixin, Wang Mengyun, Zhang Ruoxin, Sun Menghong, Zhu Xiaodong, Wang Yanong, Wei Qing
| Association between the ERCC1 polymorphism and platinum-based chemotherapy effectiveness in ovarian cancer: a meta-analysis.
BMC women's health 2017 Jun 17 (1): 43.
Tang Ning, Lyu Dan, Zhang Yan, Liu Haipi
| Association of ERCC1 Polymorphisms with the Risk of Colorectal Cancer: A Meta-Analysis.
Critical reviews in eukaryotic gene expression 2017 27 (3): 267-275.
Chen Jianfeng, Sun Ningjie, Hu Gang, Chen Xiansheng, Jiang Jiansong, Wu Haiming, Luo Gaoji
| Evaluation of Prediction of Polymorphisms of DNA Repair Genes on the Efficacy of Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer: A Network Meta-Analysis.
Journal of cellular biochemistry 2017 12 118 (12): 4782-4791.
Yu Shao-Nan, Liu Gui-Feng, Li Xue-Feng, Fu Bao-Hong, Dong Li-Xin, Zhang Shu-H
| Pharmacogenetic and ethnicity influence on oxaliplatin therapy for colorectal cancer: a meta-analysis.
Pharmacogenomics 2016 Sep .
Shahnam Adel, Ridha Zainab, Wiese Michael D, Kichenadasse Ganessan, Sorich Michael
| A meta-analysis identifies ERCC1 gene polymorphism as a predictor of better patient response to treatment with radiochemotherapy.
Cancer chemotherapy and pharmacology 2016 Apr .
Li Fengying, Xie Xinyou, Ren Xiaobin, Zhang J
| A Significant Statistical Advancement on the Predictive Values of ERCC1 Polymorphisms for Clinical Outcomes of Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer: An Updated Meta-Analysis.
Disease markers 2016 2016 7643981.
Han Yali, Liu Jie, Sun Meili, Zhang Zongpu, Liu Chuanyong, Sun Yupi
| Predictive Value of Ercc1 and Xpd Polymorphisms for Clinical Outcomes of Patients Receiving Neoadjuvant Therapy: A Prisma-Compliant Meta-Analysis.
Medicine 2015 Sep 94 (39): e1593.
Qixing Mao, Gaochao Dong, Wenjie Xia, Rong Yin, Feng Jiang, Lin Xu, Mantang Qiu, Qiang Ch
| A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Apr 26 (4): 624-44.
Findlay J M, Middleton M R, Tomlinson
| Association between the ERCC1 rs11615 polymorphism and clinical outcomes of oxaliplatin-based chemotherapies in gastrointestinal cancer: a meta-analysis.
OncoTargets and therapy 2015 8 641-8.
Ma Shou-Cheng, Zhao Yue, Zhang Tao, Ling Xiao-Ling, Zhao
| DNA repair gene polymorphisms do not predict response to radiotherapy-based multimodality treatment of patients with rectal cancer: a meta-analysis.
Asian Pacific journal of cancer prevention : APJCP 2015 16 (2): 713-8.
Guo Cheng-Xian, Yang Guo-Ping, Pei Qi, Yin Ji-Ye, Tan Hong-Yi, Yuan Ho
| The C8092A polymorphism in the ERCC1 gene and breast carcinoma risk: a meta-analysis of case-control studies.
International journal of clinical and experimental medicine 2015 8 (3): 3691-9.
Guo Xu-Guang, Wang Qian, Xia Yong, Zheng L
| Nucleotide excision repair gene ERCC1 19007T>C polymorphism contributes to lung cancer susceptibility: a meta-analysis.
Genetic testing and molecular biomarkers 2014 Aug 18 (8): 591-5.
Xie Fuyi, Sun Qi, Wu Shengjun, Xie Xinyou, Liu Zhiw
| Nucleotide excision repair gene polymorphisms and prognosis of non-small cell lung cancer patients receiving platinum-based chemotherapy: A meta-analysis based on 44 studies.
Biomedical reports 2014 Jul 2 (4): 452-462.
Huang Dongning, Zhou Ya
| Predicting the outcome of platinum-based chemotherapies in epithelial ovarian cancer using the 8092C/A polymorphism of ERCC1: a meta-analysis.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2014 Mar 19 (2): 128-34.
Li Yan, Hu Pei, Cao Yu, Wang Gui-ying, Wang Na, Zhou Rong-mi
| Association of Rs11615 (C>T) in the excision repair cross-complementing group 1 gene with ovarian but not gynecological cancer susceptibility: a meta-analysis.
Asian Pacific journal of cancer prevention : APJCP 2014 15 (15): 6071-4.
Ma Yong-Jun, Feng Sheng-Chun, Hu Shao-Long, Zhuang Shun-Hong, Fu Guan-H
| Association studies of ERCC1 polymorphisms with lung cancer susceptibility: a systematic review and meta-analysis.
PloS one 2014 9 (5): e97616.
Zhu Jinhong, Hua Rui-Xi, Jiang Jing, Zhao Li-Qin, Sun Xiuwei, Luan Jinwei, Lang Yaoguo, Sun Yanqi, Shang Kun, Peng Shiyun, Ma Jianq
| The ERCC1 C118T polymorphism predicts clinical outcomes of colorectal cancer patients receiving oxaliplatin-based chemotherapy: a meta-analysis based on 22 studies.
Asian Pacific journal of cancer prevention : APJCP 2014 15 (19): 8383-90.
Qian Ying-Ying, Liu Xin-You, Wu Qian, Song Xian, Chen Xiao-Feng, Liu Yi-Qian, Pei Dong, Shen Li-Zong, Shu Yong-Qi